HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S El-Dika Selected Research

Sunitinib (Sutent)

7/2015A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal and gastro-oesophageal cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S El-Dika Research Topics

Disease

2Gastroesophageal Reflux (GERD)
02/2006 - 11/2004
1Diverticulitis
03/2016
1Neoplasms (Cancer)
07/2015
1Heartburn (Pyrosis)
02/2006

Drug/Important Bio-Agent (IBA)

2Esomeprazole (Nexium)FDA Link
02/2006 - 11/2004
1Immunosuppressive Agents (Immunosuppressants)IBA
03/2016
1Sunitinib (Sutent)FDA Link
07/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2015
1TabletsIBA
02/2006
1AntacidsIBA
02/2006

Therapy/Procedure

1Therapeutics
03/2016
1Aftercare (After-Treatment)
11/2004